Inspire Medical Systems Quarterly Balance Sheets Chart
Quarterly
|
Annual
Inspire Medical Systems Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||
| cash and cash equivalents | 106,927,000 | 53,882,000 | 150,150,000 | 147,512,000 | 188,035,000 | 175,416,000 | 185,537,000 | 329,897,000 | 467,051,000 | 442,132,000 | 441,592,000 | 417,808,000 | 186,570,000 | 203,291,000 | 214,467,000 | 210,200,000 | 176,541,000 | 182,348,000 | 190,518,000 | 178,705,000 | 211,237,000 | 76,117,000 | 22,860,000 | 48,044,000 | 51,268,000 | 101,945,000 | 97,288,000 | 26,312,000 |
| investments, short-term | 193,968,000 | 315,307,000 | 295,396,000 | 263,475,000 | 251,629,000 | 265,945,000 | 274,838,000 | 134,317,000 | 9,927,000 | 9,821,000 | 9,741,000 | 9,752,000 | 31,295,000 | 43,796,000 | 43,844,000 | 55,932,000 | 31,322,000 | 59,608,000 | 126,605,000 | 103,558,000 | 107,352,000 | |||||||
| accounts receivable | 137,687,000 | 92,628,000 | 93,068,000 | 89,743,000 | 79,716,000 | 72,333,000 | 89,884,000 | 71,460,000 | 63,500,000 | 59,766,000 | 61,228,000 | 48,498,000 | 40,380,000 | 34,544,000 | 34,179,000 | 26,675,000 | 24,914,000 | 21,646,000 | 25,063,000 | 21,101,000 | 10,235,000 | 11,032,000 | 13,131,000 | 10,985,000 | 9,465,000 | 7,036,000 | 6,667,000 | 5,410,000 |
| inventories | 121,633,000 | 99,727,000 | 80,118,000 | 67,432,000 | 59,025,000 | 48,974,000 | 33,885,000 | 26,115,000 | 20,840,000 | 15,663,000 | 11,886,000 | 15,146,000 | 21,857,000 | 22,198,000 | 17,231,000 | 15,574,000 | 13,296,000 | 11,385,000 | 8,479,000 | 8,966,000 | 9,966,000 | 7,245,000 | 5,834,000 | 4,675,000 | 3,561,000 | 3,106,000 | 2,667,000 | 3,075,000 |
| prepaid expenses and other current assets | 12,974,000 | 10,135,000 | 12,074,000 | 14,358,000 | 28,755,000 | 9,546,000 | 9,595,000 | 7,802,000 | 8,685,000 | 6,090,000 | 5,505,000 | 4,351,000 | 4,574,000 | 2,444,000 | 2,660,000 | 3,046,000 | 3,448,000 | 1,609,000 | 1,965,000 | 2,219,000 | 4,348,000 | 1,429,000 | 2,206,000 | 3,200,000 | 5,596,000 | 1,387,000 | ||
| total current assets | 573,189,000 | 571,679,000 | 630,806,000 | 582,520,000 | 607,160,000 | 572,214,000 | 593,739,000 | 569,591,000 | 560,076,000 | 533,578,000 | 530,032,000 | 495,544,000 | 263,133,000 | 262,477,000 | 268,537,000 | 255,495,000 | 249,494,000 | 260,784,000 | 269,869,000 | 266,923,000 | 267,108,000 | 155,431,000 | 170,636,000 | 170,462,000 | 177,242,000 | 188,543,000 | 199,278,000 | 129,955,000 |
| investments, long-term | 109,830,000 | 44,831,000 | 70,995,000 | 113,425,000 | 26,344,000 | 27,803,000 | 9,143,000 | 2,961,000 | 9,796,000 | 9,938,000 | 9,984,000 | 9,979,000 | 6,139,000 | 6,276,000 | 9,625,000 | 6,116,000 | ||||||||||||
| property and equipment | 85,274,000 | 77,175,000 | 71,925,000 | 67,447,000 | 61,701,000 | 52,281,000 | 39,984,000 | 32,249,000 | 25,217,000 | 20,920,000 | 17,249,000 | 14,134,000 | 11,015,000 | 9,334,000 | 8,486,000 | 7,915,000 | 7,066,000 | 6,791,000 | 5,311,000 | 4,309,000 | 3,307,000 | 3,113,000 | 3,045,000 | 2,757,000 | 1,826,000 | 974,000 | 802,000 | 765,000 |
| operating lease right-of-use assets | 24,524,000 | 24,972,000 | 23,314,000 | 21,811,000 | 22,189,000 | 22,248,000 | 22,667,000 | 23,081,000 | 21,368,000 | 6,614,000 | 6,880,000 | 7,141,000 | 7,400,000 | |||||||||||||||
| other non-current assets | 9,376,000 | 12,152,000 | 11,343,000 | 10,991,000 | 10,995,000 | 11,296,000 | 11,278,000 | 11,612,000 | 11,585,000 | 10,735,000 | 10,715,000 | 10,704,000 | 10,454,000 | 454,000 | 204,000 | 204,000 | 204,000 | 204,000 | 204,000 | 381,000 | 469,000 | |||||||
| total assets | 802,193,000 | 730,809,000 | 808,383,000 | 796,194,000 | 728,389,000 | 685,842,000 | 676,811,000 | 639,494,000 | 618,246,000 | 571,847,000 | 564,876,000 | 527,523,000 | 292,002,000 | 289,720,000 | 295,084,000 | 278,894,000 | 272,208,000 | 273,413,000 | 281,189,000 | 271,784,000 | 271,308,000 | 165,736,000 | 181,253,000 | 183,225,000 | 185,565,000 | 189,606,000 | 200,080,000 | 130,720,000 |
| liabilities and stockholders' equity | ||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||
| accounts payable | 53,162,000 | 29,137,000 | 38,687,000 | 34,926,000 | 33,621,000 | 43,802,000 | 38,839,000 | 40,031,000 | 39,961,000 | 36,478,000 | 26,847,000 | 20,305,000 | 16,033,000 | 17,022,000 | 11,665,000 | 9,989,000 | 8,681,000 | 9,057,000 | 7,209,000 | 6,743,000 | 5,103,000 | 5,821,000 | 4,459,000 | 4,838,000 | 2,681,000 | 3,203,000 | 3,429,000 | 2,449,000 |
| accrued expenses | 40,197,000 | 34,333,000 | 49,814,000 | 39,338,000 | 32,036,000 | 28,370,000 | 39,266,000 | 29,964,000 | 26,726,000 | 23,390,000 | 34,339,000 | 28,986,000 | 18,570,000 | 13,896,000 | 20,454,000 | 17,477,000 | 12,606,000 | 10,365,000 | 13,516,000 | 11,455,000 | 7,939,000 | 7,896,000 | 12,397,000 | 7,865,000 | 5,980,000 | 4,623,000 | 7,726,000 | 4,962,000 |
| total current liabilities | 93,359,000 | 63,470,000 | 88,501,000 | 74,264,000 | 65,657,000 | 72,172,000 | 78,105,000 | 69,995,000 | 66,687,000 | 59,868,000 | 61,186,000 | 49,291,000 | 46,853,000 | 43,168,000 | 41,307,000 | 33,591,000 | 24,350,000 | 19,422,000 | 20,725,000 | 18,198,000 | 13,042,000 | 13,717,000 | 16,856,000 | 12,703,000 | 8,661,000 | 7,826,000 | 11,155,000 | 7,595,000 |
| operating lease liabilities, non-current portion | 30,909,000 | 31,488,000 | 30,039,000 | 25,218,000 | 24,512,000 | 24,500,000 | 24,846,000 | 25,173,000 | 22,054,000 | 7,185,000 | 7,536,000 | 7,882,000 | 8,224,000 | |||||||||||||||
| other non-current liabilities | 111,000 | 108,000 | 148,000 | 150,000 | 149,000 | 146,000 | 1,346,000 | 146,000 | 146,000 | 146,000 | 146,000 | 146,000 | 146,000 | 146,000 | ||||||||||||||
| total liabilities | 124,379,000 | 95,066,000 | 118,688,000 | 99,632,000 | 90,318,000 | 96,818,000 | 104,297,000 | 95,314,000 | 88,887,000 | 67,199,000 | 68,868,000 | 57,319,000 | 65,018,000 | 64,665,000 | 66,036,000 | 58,594,000 | 52,294,000 | 50,282,000 | 51,442,000 | 42,961,000 | 37,714,000 | 38,333,000 | 41,418,000 | 37,171,000 | 33,076,000 | 32,190,000 | 36,081,000 | |
| stockholders' equity: | ||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||||||||||
| common stock | 29,000 | 29,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 29,000 | 29,000 | 29,000 | 29,000 | 29,000 | 28,000 | 28,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 24,000 | 24,000 | 24,000 | 24,000 | 23,000 | 21,000 | |
| additional paid-in capital | 969,903,000 | 924,409,000 | 981,043,000 | 1,021,970,000 | 983,791,000 | 944,298,000 | 917,107,000 | 904,293,000 | 880,873,000 | 844,281,000 | 820,335,000 | 797,958,000 | 537,730,000 | 521,308,000 | 508,465,000 | 497,280,000 | 486,550,000 | 476,658,000 | 467,038,000 | 458,586,000 | 452,891,000 | 323,473,000 | 319,865,000 | 317,016,000 | 315,243,000 | 312,555,000 | 310,941,000 | 240,451,000 |
| accumulated other comprehensive income | 396,000 | 227,000 | 536,000 | 1,700,000 | -115,000 | 124,000 | 800,000 | 44,000 | 103,000 | 32,000 | -55,000 | -9,000 | -12,000 | 9,000 | 29,000 | 73,000 | 154,000 | 295,000 | 102,000 | 90,000 | 51,000 | 16,000 | ||||||
| accumulated deficit | -292,514,000 | -288,922,000 | -291,914,000 | -327,138,000 | -345,635,000 | -355,428,000 | -345,423,000 | -360,186,000 | -351,646,000 | -339,694,000 | -324,270,000 | -327,420,000 | -310,573,000 | -296,083,000 | -279,389,000 | -276,998,000 | -266,651,000 | -253,563,000 | -237,347,000 | -229,863,000 | -219,478,000 | -196,389,000 | -180,156,000 | -171,076,000 | -162,829,000 | -155,179,000 | -146,913,000 | -142,135,000 |
| total stockholders' equity | 677,814,000 | 635,743,000 | 689,695,000 | 696,562,000 | 638,071,000 | 589,024,000 | 572,514,000 | 544,180,000 | 529,359,000 | 504,648,000 | 496,008,000 | 470,204,000 | 226,984,000 | 225,055,000 | 229,048,000 | 220,300,000 | 219,914,000 | 223,131,000 | 229,747,000 | 228,823,000 | 233,594,000 | 127,403,000 | 139,835,000 | 146,054,000 | 152,489,000 | 157,416,000 | 163,999,000 | 98,311,000 |
| total liabilities and stockholders' equity | 802,193,000 | 730,809,000 | 808,383,000 | 796,194,000 | 728,389,000 | 685,842,000 | 676,811,000 | 639,494,000 | 618,246,000 | 571,847,000 | 564,876,000 | 527,523,000 | 292,002,000 | 289,720,000 | 295,084,000 | 278,894,000 | 272,208,000 | 273,413,000 | 281,189,000 | 271,784,000 | 271,308,000 | 165,736,000 | 181,253,000 | 183,225,000 | 185,565,000 | 189,606,000 | 200,080,000 | 130,720,000 |
| commitments and contingencies | ||||||||||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||||||||||
| notes payable, current portion | 12,250,000 | 12,250,000 | 9,188,000 | |||||||||||||||||||||||||
| notes payable, non-current portion | 9,795,000 | 12,798,000 | 15,799,000 | 18,799,000 | 21,801,000 | |||||||||||||||||||||||
| accumulated other comprehensive loss | -86,000 | -363,000 | -201,000 | -198,000 | -52,000 | -26,000 | ||||||||||||||||||||||
| operating lease right-of-use asset | 7,659,000 | 7,919,000 | 5,296,000 | 5,465,000 | 5,634,000 | 5,805,000 | 171,000 | 424,000 | 672,000 | 915,000 | ||||||||||||||||||
| operating lease liability, non-current portion | 8,553,000 | 8,796,000 | 6,080,000 | 6,032,000 | 5,959,000 | 5,886,000 | ||||||||||||||||||||||
| other non-current liability | 134,000 | 124,000 | 111,000 | 97,000 | 85,000 | 74,000 | 40,000 | 40,000 | 40,000 | |||||||||||||||||||
| current portion of notes payable | 6,125,000 | 3,063,000 | ||||||||||||||||||||||||||
| notes payable | 24,804,000 | 24,746,000 | 24,689,000 | 24,632,000 | 24,576,000 | 24,522,000 | 24,468,000 | 24,415,000 | 24,364,000 | 24,926,000 | 24,814,000 | |||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||
| total non-current liabilities | 30,717,000 | |||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||
| other non-current asset | 381,000 | 381,000 | 381,000 | 381,000 | 89,000 | |||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||
| common stock,0.001 par value per share; 200,000,000 shares authorized at september 30, 2019 and december 31, 2018; 24,038,369 and 23,401,675 issued and outstanding at september 30, 2019 and december 31, 2018, respectively | 24,000 | |||||||||||||||||||||||||||
| short-term investments | 75,069,000 | 90,922,000 | 94,114,000 | |||||||||||||||||||||||||
| prepaid expenses and other assets | 1,734,000 | 1,044,000 | ||||||||||||||||||||||||||
| preferred stock warrants | ||||||||||||||||||||||||||||
| total long-term liabilities | 24,926,000 | 24,814,000 | ||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares and 76,894,620 shares authorized at december 31, 2018 and 2017, respectively; none and 76,235,050 shares issued and outstanding at december 31, 2018 and 2017, respectively | ||||||||||||||||||||||||||||
| property and equipment, cost | 1,553,000 | |||||||||||||||||||||||||||
| less: accumulated depreciation | -788,000 | |||||||||||||||||||||||||||
| accrued interest | 184,000 | |||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000,000 shares and 76,894,620 shares authorized at september 30, 2018 and december 31, 2017, respectively; none and 76,235,050 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively |
We provide you with 20 years of balance sheets for Inspire Medical Systems stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Inspire Medical Systems. Explore the full financial landscape of Inspire Medical Systems stock with our expertly curated balance sheets.
The information provided in this report about Inspire Medical Systems stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.